Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/10/2019
Auction - Pharma Site Closure in XiAn, China (Bid Due by April 12)
4/10/2019
Takeda Completes China Business Restructure Following Shire Acquisitio...
4/10/2019
Ascentage Announces Clinical Collaboration with Junshi Bio to Evaluate...
4/10/2019
Antengene Announces U.S. Subsidiary and Collaboration with the Blumber...
4/10/2019
China Improves Healthcare Resource Sharing Thru Increased Cooperation ...
4/5/2019
Upcoming Event: Pharma China Annual Forum 2019 (April 9, Shanghai)
4/5/2019
NMPA Solicits Comments on New Document on Linked Evaluation and Approv...
4/5/2019
Recent Executive Moves
4/4/2019
NMPA Issues New Announcement (2019#21) for Clinical Data Self-Inspecti...
4/3/2019
Deloitte Report: The Future of Life Sciences and Health Care in Asia P...
4/3/2019
Novartis CEO Expects China to Become One of Its Three Top Markets in t...
4/3/2019
FDA'S Pazdur Encourages Chinese Companies To Bring Low-Cost PD-1 Drugs...
4/3/2019
PharmExec: Use of External Innovation in China
4/3/2019
Adlai Nortye Receives NMPA Approval for Phase III Trials of Pelareorep
4/3/2019
Sichuan Haisco Acquires Stake in eXithera and Right to Its Novel Anti-...
4/3/2019
China to Regulate All Fentanyl Drugs as Controlled Substance
4/3/2019
Savolitinib Co-developed by Chi-Med and AZ Helpful to Some Tagrisso-r...
4/2/2019
State Council Approves Establishment of the System of Inter-ministeria...
4/1/2019
MSD's KEYTRUDA Approved in China for First-Line Treatment of NSCLC in ...
4/1/2019
Novartis Gains Chinese Approval of Psoriasis Drug Consentyx
4/1/2019
NHC Solicits Comments on Draft Rules for Clinical Research and Transla...
4/1/2019
NHC Issues Notice to Enhance Clinical Application Regulation of Anti-i...
4/1/2019
MNCs Need Perseverance as China Ratchets Up Cost Containment amid Econ...
4/1/2019
Nicholas Hall Reports 8% Growth of OTC Gastrointestinal Market in Chin...
4/1/2019
China to Promote Standardized Treatment of Breast Cancer
3/30/2019
Financial-related Company News in Brief
3/29/2019
AstraZeneca to Co-found New Life Science Research Hub in Wuxi
3/29/2019
Recent Executive Movements
3/29/2019
NMPA Releases List of Reference Formulations for Generic Drug Equivale...
3/29/2019
Luye Pharma's Rykindo Expected to Be the First Chinese Innovative Drug...
Page:
232
/
720
Total number of articles:
21572
:
[First]
[<<]
[230]
[231]
[232]
[233]
[234]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit